好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and safety of Fingolimod: the French Grand-Est Cohort
Multiple Sclerosis
(-)
249
Authors/Disclosures
Leah Shabo
PRESENTER
No disclosure on file
No disclosure on file
Marc Debouverie, MD (Hospital Central) Dr. Debouverie has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Etienne Godet (Chr De Metz) No disclosure on file
Galina Vorobeychik, MD, FRCPC, FAAN (Fraser Health MS Clinic) Dr. Vorobeychik has nothing to disclose.
Thibault Moreau Thibault Moreau has nothing to disclose.